CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to B-cell Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk
- Status
- UNKNOWN
- Phase
- N/A
The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).
- Status
- UNKNOWN
- Phase
- PHASE1
Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia
- Status
- COMPLETED
- Phase
- PHASE1
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of CTL019 in Adult ALL Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
- Status
- SUSPENDED
- Phase
- PHASE1
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE2
Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2